BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36692397)

  • 41. Can
    Du B; Wang S; Cui Y; Liu G; Li X; Li Y
    BMJ Open; 2021 Jun; 11(6):e044313. PubMed ID: 34103313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y; Wang L; Jiang X; She W; He L; Hu G
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
    Kim DH; Kim SJ
    Clin Imaging; 2020 Sep; 65():100-107. PubMed ID: 32387798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic test accuracy of
    Seol HY; Kim YS; Kim SJ
    Clin Radiol; 2021 Nov; 76(11):863.e19-863.e25. PubMed ID: 34261597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-Body [
    Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
    Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Kim K; Kim SJ
    Hell J Nucl Med; 2021; 24(2):132-139. PubMed ID: 34352048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
    Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
    Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of (18)F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
    Liu Q; Wang C; Li P; Liu J; Huang G; Song S
    Biomed Res Int; 2016; 2016():3746232. PubMed ID: 26981529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
    Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
    Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
    Cronin P; Dwamena BA; Kelly AM; Carlos RC
    Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
    Treglia G; Salsano M; Stefanelli A; Mattoli MV; Giordano A; Bonomo L
    Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic performance of
    Treglia G; Pascale M; Lazzeri E; van der Bruggen W; Delgado Bolton RC; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1287-1301. PubMed ID: 31729539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
    Dubreuil J; Tordo J; Rubello D; Giammarile F; Skanjeti A
    Nucl Med Commun; 2017 Jan; 38(1):84-90. PubMed ID: 27898647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L
    Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance of F-18 FDG PET/CT in the detection of bone marrow involvement in paediatric hodgkin lymphoma: A meta-analysis.
    Kim K; Kim SJ
    Leuk Res; 2021 Mar; 102():106525. PubMed ID: 33607533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature.
    Wang N; Jiang P; Lu Y
    Urol Int; 2014; 92(2):143-9. PubMed ID: 23941766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.